We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
14.00 | 0.80% | 1,775.00 | 1,774.50 | 1,775.00 | 1,775.00 | 1,766.00 | 1,770.00 | 681,596 | 11:22:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.80 | 72.91B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/6/2020 15:58 | Could be tempted to add a few at 1600p | gateside | |
11/6/2020 14:54 | Wrong thread. Toodle pip. | daveboy1 | |
11/6/2020 14:48 | TM every thing is caught in the Corona trap,whether the markets go up or down it is not relevant. | abdullla | |
11/6/2020 13:11 | Not good: GBP 1.0 = 1.27 USD | tradermichael | |
11/6/2020 07:36 | https://youtu.be/zCU | applepieinthesky | |
11/6/2020 06:58 | FTSE and Dow looking ugly today. | montyhedge | |
10/6/2020 17:25 | I quote "During the year, Group sales grew to £33.8 billion, up ten per cent AER. We successfully integrated Tesaro into the business and in July we completed the acquisition of the Pfizer consumer healthcare business. We built capability in priority areas including Oncology, and continued delivery on restructuring benefits to support investment in innovation and new launches. We also invested new talent to build capability. Performance objectives for 2020 include prioritising spending to deliver growth and return on investment, and delivering further capability-building in speciality Pharmaceuticals ". | roybel | |
10/6/2020 09:00 | Back to the future,what game is this? | abdullla | |
10/6/2020 07:48 | Why she doing this, waste of money. | montyhedge | |
09/6/2020 17:42 | From 45p up to 2p up,good forecast ! | abdullla | |
09/6/2020 16:07 | GSK is investing $250m in San-Francisco-based start-up Vir Biotechnology to develop antibodies that could be used to treat coronavirus. Would Emma ok all this if it was thought to be worthless ? | roybel | |
09/6/2020 14:11 | In this word nothing comes free,the vaccine profits will be changed under a different name like,costs & sundries etc | abdullla | |
09/6/2020 13:40 | But it's non profit making venture for Coronavirus vaccine I thought these companies said. | montyhedge | |
09/6/2020 13:07 | Sanofi & GSK have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID 19. Using innovative technology from both companies. GSK has announced plans to collaborate with China's Xiamen Innovex on a potential vaccine to treat the COVID 10 coronavirus, (COVID-19 XWG-03) AZ, GSK and Cambridge University will set up a COVID-19 testing centre. | roybel | |
09/6/2020 11:49 | billionairepaddyI am already there,I just got to enter a few teasers here to keep you all warm and kicking ! | abdullla | |
09/6/2020 11:06 | do yourself a favour abdul and buy some if you can for a juicy 80p per year | billionairepaddy | |
09/6/2020 10:30 | Soon to go in red,so much on your takeover story. | abdullla | |
09/6/2020 09:36 | There is a remote chance of a merger but no chance of any body buying GSK,dream on . | abdullla | |
09/6/2020 08:50 | Americans looking to buy at GSK at around £24 | inv | |
08/6/2020 09:09 | Post-Brexit stockpiles of medical supplies have been “used up entirely” due to the coronavirus pandemic, according to a warning from the UK’s pharmaceutical industry. The memo warns that, compared to 2019, when significant stockpiling for a potential no-deal Brexit last occurred, the pandemic means that there will be “less or zero product available to allow for stockpiling a broad range of products.” | tradermichael | |
08/6/2020 06:57 | GSK shares will open down, if Astra bid for Gilead, it would create a massive competitor for GSK. | montyhedge | |
07/6/2020 17:52 | I think GSK will look like a bargain to a US suitor if mergers and acquisitions are going to occur. Interesting day ahead tomorrow for big pharma shares. | robbiekeane | |
07/6/2020 14:31 | The share to hold is Gilead which will pop tomorrow. ALL IMO. DYOR. QP | quepassa | |
07/6/2020 14:18 | Like most here I hold both, bought as equal holdings which are far from equal now. Azn star of show and I hope it’s not about to stumble, although CEO is brilliant. There must be big savings that could be made by mergers and suspect market will like the prospect. Hopefully GSK glows in the possibilities if not the action. | mac15 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions